Trial Profile
Role of Rosiglitazone Treatment and Secondary Prevention of Cardiovascular Events in Patients With Pre-Diabetes Mellitus and Coronary Artery Disease
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Rosiglitazone (Primary)
- Indications Coronary artery disease; Coronary disorders; Insulin resistance
- Focus Therapeutic Use
- 20 Apr 2012 New trial record